Camurus

Camurus

Sweden - Lund
Biotechnology

Focus: Specialty medicines

Camurus is a life sciences company focused on Specialty medicines.

EndocrinologyOncologyGastroenterologyUnknown
Funding Stage
PUBLIC
Employees
201-500
Open Jobs
1

Pipeline & Clinical Trials

Clinical Trials (1)
NCT01684566A Comparative Investigation of Standard Of Care (SOC) and Episil® in Combination Versus SOC Alone on Oral Mucositis
N/A
leuprolide acetate FluidCrystal® injection depot
Prostate Cancer
Phase 2
Clinical Trials (1)
NCT02212197Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer
Phase 2
octreotide FluidCrystal® injection depot
Acromegaly
Phase 2
Phase 2/3
Clinical Trials (1)
NCT05281328A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD
Phase 2/3
Phase 3
CAM2029
Acromegaly
Phase 3
Clinical Trials (1)
NCT04076462A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
Phase 3
CAM2029
Acromegaly
Phase 3
Clinical Trials (1)
NCT04125836A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
Phase 3
Clinical Trials (1)
NCT05050942A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET
Phase 3
XER2020
Xerostomia
Phase 4
Clinical Trials (1)
NCT01316393Effects of Mucoprotective Product on Xerostomia
Phase 4

Open Jobs (1)

Interview Prep Quick Facts
Portfolio: 7 clinical trials
Open Roles: 1 active job